M
Morris Sherman
Researcher at Toronto General Hospital
Publications - 75
Citations - 19976
Morris Sherman is an academic researcher from Toronto General Hospital. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatitis C. The author has an hindex of 35, co-authored 72 publications receiving 18457 citations. Previous affiliations of Morris Sherman include University Health Network & Saint Louis University.
Papers
More filters
Journal ArticleDOI
Management of hepatocellular carcinoma: An update
Jordi Bruix,Morris Sherman +1 more
TL;DR: The American Association for the Study of Liver Diseases (AASLD) practice guidelines on the management of hepatocellular carcinoma (HCC) were updated in 2010 as discussed by the authors.
Journal ArticleDOI
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Jordi Bruix,Morris Sherman,Josep M. Llovet,Michel Beaugrand,Riccardo Lencioni,Andrew K. Burroughs,Erik Christensen,Luigi Pagliaro,Massimo Colombo,Juan Rodés +9 more
Journal ArticleDOI
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
Josep M. Llovet,Adrian M. Di Bisceglie,Jordi Bruix,Barnett S. Kramer,Riccardo Lencioni,Andrew X. Zhu,Morris Sherman,Myron Schwartz,Michael Lotze,Jayant A. Talwalkar,Gregory J. Gores +10 more
TL;DR: These guidelines provide a common framework for designing trials to facilitate comparability of results, and randomized phase 2 trials with a time-to-event primary endpoint, such as time to progression, are pivotal in clinical research on HCC.
Journal ArticleDOI
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
Mariana Capurro,Ian R. Wanless,Morris Sherman,Gerrit DeBoer,Wen Shi,Eiji Miyoshi,Jorge Filmus +6 more
TL;DR: GPC3 is specifically overexpressed in most HCCs and is elevated in the serum of a large proportion of patients with HCC, suggesting that the simultaneous determination of GPC3 and AFP may significantly increase the sensitivity for diagnosis of HCC.
Journal ArticleDOI
Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study
Joong-Won Park,Minshan Chen,Massimo Colombo,Lewis R. Roberts,Myron Schwartz,Pei-Jer Chen,Masatoshi Kudo,Philip J. Johnson,Samuel Wagner,L. Orsini,Morris Sherman +10 more
TL;DR: The global HCC BRIDGE study was a multiregional, large‐scale, longitudinal cohort study undertaken to improve understanding of real‐life management of patients with HCC, from diagnosis to death.